Incannex Healthcare Inc. (Nasdaq: IXHL) has received approval from the US Food and Drug Administration (FDA) to begin its Phase 2 clinical trial studying psilocybin on patients with generalized anxiety disorder (GAD). The trial uses Incannex’s psilocybin compound known as PSX-001. The psilocybin treatment is also accompanied by psychotherapy. Incannex …
MarTech Series’s Marketing Technology Highlights of The Week: Featuring Pendo, ON24, Outbrain and more in martech!
How can B2B tech marketers leverage social media effectively to drive marketing journeys? And what new martech integrations should marketers be updated about? Find out more from this week’s martech highlight: __________ Marketing and Marketing Tech Quote-of-the-Week! Identity is important. People don’t show up as single entities on the internet, …
Ohioans can start buying recreational marijuana in some dispensaries this week
The Division of Cannabis Control has received 230 applications to switch medical marijuana … In Rhode Island’s payday lending wilderness, a strong …